An artificial-intelligence approach created at Carolina could help bring new drugs to patients quicker.
An artificial-intelligence approach created at the University of North Carolina at Chapel Hill Eshelman School of Pharmacy can teach itself to design new drug molecules from scratch and has the potential to dramatically accelerate the design of new drug candidates.
The system is called Reinforcement Learning for Structural Evolution, known as ReLeaSE, and is an algorithm and computer program that comprises two neural networks which can be thought of as a teacher and a student. The teacher knows the syntax and linguistic rules behind the vocabulary of chemical structures for about 1.7 million known biologically active molecules. By working with the teacher, the student learns over time and becomes better at proposing molecules that are likely to be useful as new medicines.
Alexander Tropsha, Olexandr Isayev and Mariya Popova, all of the UNC Eshelman School of Pharmacy, are the creators of ReLeaSE. The University has applied for a patent for the technology, and the team published a proof-of-concept study in the journal Science Advances last week.
“If we compare this process to learning a language, then after the student learns the molecular alphabet and the rules of the language, they can create new ‘words,’ or molecules,” said Tropsha. “If the new molecule is realistic and has the desired effect, the teacher approves. If not, the teacher disapproves, forcing the student to avoid bad molecules and create good ones.”
ReLeaSE is a powerful innovation to virtual screening, the computational method widely used by the pharmaceutical industry to identify viable drug candidates. Virtual screening allows scientists to evaluate existing large chemical libraries, but the method only works for known chemicals. ReLeASE has the unique ability to create and evaluate new molecules.
“A scientist using virtual screening is like a customer ordering in a restaurant. What can be ordered is usually limited by the menu,” said Isayev. “We want to give scientists a grocery store and a personal chef who can create any dish they want.”
The team has used ReLeaSE to generate molecules with properties that they specified, such as desired bioactivity and safety profiles.The team used the ReLeaSE method to design molecules with customized physical properties, such as melting point and solubility in water, and to design new compounds with inhibitory activity against an enzyme that is associated with leukemia.
“The ability of the algorithm to design new, and therefore immediately patentable, chemical entities with specific biological activities and optimal safety profiles should be highly attractive to an industry that is constantly searching for new approaches to shorten the time it takes to bring a new drug candidate to clinical trials,” said Tropsha.
The Latest on: Drug design
via Google News
The Latest on: Drug design
- Stoned Age: Native American art confirms hallucinogenic drug useon November 23, 2020 at 1:45 pm
For the first time, scientists have confirmed that Native Americans used a hallucinogenic drug while painting rock art, according to a new study.
- AstraZeneca to discuss with U.S. FDA changing vaccine trial designon November 23, 2020 at 12:55 pm
AstraZeneca will start discussions this week with the U.S. Food and Drug Administration (FDA) to change the design of its experimental COVID-19 vaccine trial to add a likely more effective dosage ...
- Targeting drug-resistant cancers through mathematical biology to control gene expressionon November 23, 2020 at 9:35 am
Among the things to give thanks for this year is the fact that stubborn, persistent problems seem to have an irresistible sort of magnetic pull for scientists and mathematicians. Things that would ...
- SMi’s 2nd Annual AI in Drug Discovery Announces Key Industry Speakers and Agenda Releasedon November 22, 2020 at 1:57 am
SMi’s Group is proud to announce the 2nd Annual AI in Drug Discovery Conference is back and taking place on 15th and 16th March 2021 as a virtual conference with online access only and sponsored by ...
- In silico drug discovery services market is likely to be worth USD 124 million by 2030, growing at an annualized rate of 15.6%, claims Roots Analysison November 21, 2020 at 2:12 pm
Roots Analysis has announced the addition of “In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules (Antibodies, Proteins, Peptides, Nucleic Acid, Gene Therapy and ...
- Colombian drug runners built a $1.5M electric submarine that could carry $120M of cocaineon November 19, 2020 at 6:26 pm
Colombian drug runners had their $1.5M electric submarine seized by authorities. It's one of the largest subs of its type in terms of its payload capacity.
- How One Company Pivoted From Cancer To Coronavirus And Designed A Virus-Blocking Drug In 10 Weekson November 19, 2020 at 9:33 am
Scientists at Neoleukin Therapeutics applied their protein design technology to the new coronavirus and created an antiviral molecule in record time.
- Machine learning innovation to develop chemical library for drug discoveryon November 18, 2020 at 1:11 am
Machine learning has been used widely in the chemical sciences for drug design and other processes. The models that are prospectively tested for new reaction outcomes and used to enhance human ...
- Drug addict who smiled as he ran over and killed BBC costume designer when she tried to stop him stealing her handbag will be freed AGAIN after twice going on the run while ...on November 17, 2020 at 7:05 am
Mark Woolley was jailed for life in 2001 for mowing down Elizabeth Sherlock in London. Now the Parole Board has said it is satisfied he is suitable for release, subject to strict conditions.
via Bing News